GDF11/BMP11 as a novel tumor marker for liver cancer

Zhang,Yong‑Hui; Pan,Lian‑Hong; Pang,Yi; Yang,Jin‑Xin; Lv,Meng‑Jia; Liu,Feng; Qu,Xue‑Feng; Chen,Xin‑Xin; Gong,Hua‑Jun; Liu,Dan; Wei,Yong

doi:10.3892/etm.2018.5861

GDF11/BMP11 as a novel tumor marker for liver cancer

Authors:
- Yong‑Hui Zhang
- Lian‑Hong Pan
- Yi Pang
- Jin‑Xin Yang
- Meng‑Jia Lv
- Feng Liu
- Xue‑Feng Qu
- Xin‑Xin Chen
- Hua‑Jun Gong
- Dan Liu
- Yong Wei
View Affiliations

Affiliations: Department of Basic Medical Science, Chongqing Three Gorges Medical College, Chongqing 404120, P.R. China, Chongqing Engineering Research Center of Antitumor Natural Drugs, Chongqing 404120, P.R. China, Department of Nutrition and Food Hygiene, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang 310013, P.R. China, Key Laboratory of Intelligent Information Processing and Control, College of Electronic and Information Engineering, Chongqing Three Gorges University, Chongqing 404110, P.R. China
Published online on: February 12, 2018 https://doi.org/10.3892/etm.2018.5861
Pages: 3495-3500

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Growth differentiation factor 11 (GDF11), also known as bone morphogenetic protein 11, a member of the transforming growth factor-β superfamily, has been reported to be involved in colorectal cancer. However, the roles of GDF11 in Chinese patients with liver cancer and the underlying mechanisms have remained elusive. The present study assessed the expression of GDF11 in 10 paired samples of cancerous and normal tissues from Chinese liver cancer patients. The results indicated that the expression of GDF11 was significantly lower in cancerous tissues than in normal tissues. In vitro, the expression of GDF11 was reduced in a panel of liver cancer cell lines compared with that in a normal liver cell line at the mRNA and protein level. Treatment with GDF11 reduced the viability of HepG2 for up to 72 h and GDF11 treatment reduced the viability of SMMC‑7721 after 48 and 72 h. Furthermore, GDF11 activated Smad2/3 signaling in HepG2 cells. In conclusion, GDF11 has a tumor suppressor role in liver cancer, exerts its effects through Smad2/3 signaling and may serve as a novel tumor marker in liver cancer diagnosis.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
2	Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
3	Baig JA, Alam JM, Mahmood SR, Baig M, Shaheen R, Sultana I and Waheed A: Hepatocellular carcinoma (HCC) and diagnostic significance of A-fetoprotein (AFP). J Ayub Med Coll Abbottabad. 21:72–75. 2009.PubMed/NCBI
4	Zhao YJ, Ju Q and Li GC: Tumor markers for hepatocellular carcinoma. Mol Clin Oncol. 1:593–598. 2013. View Article : Google Scholar : PubMed/NCBI
5	Nakashima M, Toyono T, Akamine A and Joyner A: Expression of growth/differentiation factor 11, a new member of the BMP/TGFbeta superfamily during mouse embryogenesis. Mech Dev. 80:185–189. 1999. View Article : Google Scholar : PubMed/NCBI
6	Gamer LW, Wolfman NM, Celeste AJ, Hattersley G, Hewick R and Rosen V: A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in Xenopus embryos. Dev Biol. 208:222–232. 1999. View Article : Google Scholar : PubMed/NCBI
7	Essalmani R, Zaid A, Marcinkiewicz J, Chamberland A, Pasquato A, Seidah NG and Prat A: In vivo functions of the proprotein convertase PC5/6 during mouse development: Gdf11 is a likely substrate. Proc Natl Acad Sci USA. 105:pp. 5750–5755. 2008; View Article : Google Scholar : PubMed/NCBI
8	Tsuda T, Iwai N, Deguchi E, Kimura O, Ono S, Furukawa T, Sasaki Y, Fumino S and Kubota Y: PCSK5 and GDF11 expression in the hindgut region of mouse embryos with anorectal malformations. Eur J Pediatr Surg. 21:238–241. 2011. View Article : Google Scholar : PubMed/NCBI
9	Rochette L, Zeller M, Cottin Y and Vergely C: Growth and differentiation factor 11 (GDF11): Functions in the regulation of erythropoiesis and cardiac regeneration. Pharmacol Ther. 156:26–33. 2015. View Article : Google Scholar : PubMed/NCBI
10	Camici GG, Savarese G, Akhmedov A and Lüscher TF: Molecular mechanism of endothelial and vascular aging: Implications for cardiovascular disease. Eur Heart J. 36:3392–3403. 2015. View Article : Google Scholar : PubMed/NCBI
11	Yokoe T, Ohmachi T, Inoue H, Mimori K, Tanaka F, Kusunoki M and Mori M: Clinical significance of growth differentiation factor 11 in colorectal cancer. Int J Oncol. 31:1097–1101. 2007.PubMed/NCBI
12	Smith SC, Zhang X, Zhang X, Gross P, Starosta T, Mohsin S, Franti M, Gupta P, Hayes D, Myzithras M, et al: GDF11 does not rescue aging-related pathological hypertrophy. Circ Res. 117:926–932. 2015. View Article : Google Scholar : PubMed/NCBI
13	Loffredo FS, Steinhauser ML, Jay SM, Gannon J, Pancoast JR, Yalamanchi P, Sinha M, Dall'Osso C, Khong D, Shadrach JL, et al: Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 153:828–839. 2013. View Article : Google Scholar : PubMed/NCBI
14	Zhang YH, Cheng F, Du XT, Gao JL, Xiao XL, Li N, Li SL and Dong de L: GDF11/BMP11 activates both Smad1/5/8 and Smad2/3 signals but shows no significant effect on proliferation and migration of human umbilical vein endothelial cells. Oncotarget. 7:11063–11074. 2016.
15	Farooq M, SuLochana KN, Pan X, To J, Sheng D, Gong Z and Ge R: Histone deacetylase3(HDAC3) is specifically required for liver development in zebrafish. Dev Biol. 317:336–353. 2008. View Article : Google Scholar : PubMed/NCBI
16	Bajikar SS, Wang CC, Borten MA, Pereira EJ, Atkins KA and Janes KA: Tumor-suppressor inactivation of GDF11 occurs by precursor sequestration in triple-negative breast cancer. Dev Cell. 43:418–435. 2017. View Article : Google Scholar : PubMed/NCBI
17	Alvarez C, Aravena A, Tapia T, Rozenblum E, Solís L, Corvalán A, Camus M, Alvarez M, Munroe D, Maass A and Carvallo P: Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival. BMC Cancer. 16:2192016. View Article : Google Scholar : PubMed/NCBI
18	Auguściak-Duma A and Sieroń AL: Molecular characteristics of leiomyoma uteri based on selected compounds of the extracellular matrix. Postepy Hig Med Dosw (Online). 62:148–165. 2008.(In Polish). PubMed/NCBI
19	McNally EM: Questions and answers about myostatin, GDF11, and the aging heart. Circ Res. 118:6–8. 2016. View Article : Google Scholar : PubMed/NCBI
20	López-Terrada D, Cheung SW, Finegold MJ and Knowles BB: Hep G2 is a hepatoblastoma-derived cell line. Hum Pathol. 40:1512–1515. 2009. View Article : Google Scholar
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
22	Sheng Y, Sun B, Guo WT, Liu X, Wang YC, Xie X, Xiao XL, Li N and Dong DL: [4-(6-(4-isopropoxyphenyl)pyrazolo(1,5-a)pyrimidin-3-yl)quinoline] is a novel inhibitor of autophagy. Br J Pharmacol. 171:4970–4980. 2014. View Article : Google Scholar : PubMed/NCBI
23	Dwivedi SK, McMeekin SD, Slaughter K and Bhattacharya R: Role of TGF-β signaling in uterine carcinosarcoma. Oncotarget. 6:14646–14655. 2015. View Article : Google Scholar : PubMed/NCBI
24	Levy L and Hill CS: Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev. 17:41–58. 2006. View Article : Google Scholar : PubMed/NCBI
25	Prunier C, Ferrand N, Frottier B, Pessah M and Atfi A: Mechanism for mutational inactivation of the tumor suppressor Smad2. Mol Cell Biol. 21:3302–3313. 2001. View Article : Google Scholar : PubMed/NCBI
26	Yang J, Wahdan-Alaswad R and Danielpour D: Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cells. Cancer Res. 69:2185–2190. 2009. View Article : Google Scholar : PubMed/NCBI
27	Millet C and Zhang YE: Roles of Smad3 in TGF-beta signaling during carcinogenesis. Crit Rev Eukaryot Gene Expr. 17:281–293. 2007. View Article : Google Scholar : PubMed/NCBI
28	Ropero S and Esteller M: The role of histone deacetylases (HDACs) in human cancer. Mol Oncol. 1:19–25. 2007. View Article : Google Scholar : PubMed/NCBI
29	Li Y and Seto E: HDACs and HDAC inhibitors in cancer development and therapy. Cold Spring Harb Perspect Med. 6(pii): a0268312016. View Article : Google Scholar : PubMed/NCBI
30	Egerman MA, Cadena SM, Gilbert JA, Meyer A, Nelson HN, Swalley SE, Mallozzi C, Jacobi C, Jennings LL, Clay I, et al: GDF11 increases with age and inhibits skeletal muscle regeneration. Cell Metab. 22:164–174. 2015. View Article : Google Scholar : PubMed/NCBI
31	Lebrun JJ: The dual role of TGFβ in human cancer: From tumor suppression to cancer metastasis. ISRN Mol Biol. 2012:3814282012. View Article : Google Scholar : PubMed/NCBI